Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Cardiol Therapeutics Inc. (CRDL)

1.03   0 (0%) 10-02 21:21
Open: 1.06 Pre. Close: 1.03
High: 1.06 Low: 1
Volume: 268,200 Market Cap: 64(M)
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx as a cardioprotective therapy to reduce cardiovascular and respiratory events in patients hospitalized with COVID-19, as well as to evaluate the efficacy and safety of CardiolRx in acute myocarditis. The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.06 - 1.07 1.07 - 1.07
Low: 0.99 - 0.99 0.99 - 1
Close: 1.02 - 1.03 1.03 - 1.04

Technical analysis

as of: 2022-09-30 4:27:11 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.41     One year: 1.56
Support: Support1: 0.99    Support2: 0.83
Resistance: Resistance1: 1.2    Resistance2: 1.34
Pivot: 1.15
Moving Average: MA(5): 1.06     MA(20): 1.15
MA(100): 1.25     MA(250): 1.72
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 19.8     %D(3): 20.9
RSI: RSI(14): 40.9
52-week: High: 4.96  Low: 0.99
Average Vol(K): 3-Month: 219 (K)  10-Days: 347 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ CRDL ] has closed above bottom band by 16.4%. Bollinger Bands are 9.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 28 Sep 2022
Cardiol Therapeutics Announces Poster Presentation at The Annual Scientific Meeting of the Heart Failure Society of America - Yahoo Finance

Fri, 09 Sep 2022
Civil Rights Digital Library Relaunches With New Look, 15 Years of Updated Content - UGA Libraries

Wed, 10 Aug 2022
We Think Cardiol Therapeutics (TSE:CRDL) Can Afford To Drive Business Growth - Simply Wall St

Wed, 22 Jun 2022
Pre-market Movers: CRDL, DNAY, AMBA, ANGH, ARR… - Nasdaq

Tue, 14 Dec 2021
Here's Why We're Watching Cordel Group's (LON:CRDL) Cash Burn Situation - Simply Wall St

Tue, 09 Nov 2021
Cardiol Therapeutics: Developing Anti-Inflammatory CBD Therapies For CVD (NASDAQ:CRDL) - Seeking Alpha

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. 62 (M)
Shares Float 56 (M)
% Held by Insiders 4.2 (%)
% Held by Institutions 13.6 (%)
Shares Short 481 (K)
Shares Short P.Month 360 (K)

Stock Financials

EPS -0.49
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -47.7
Return on Equity (ttm) -65.5
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.69
Qtrly Earnings Growth 0
Operating Cash Flow -24 (M)
Levered Free Cash Flow -9 (M)

Stock Valuations

PE Ratio -2.12
PEG Ratio 0
Price to Book value 1.01
Price to Sales 0
Price to Cash Flow -2.69

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.